BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11315346)

  • 1. Methotrexate therapy in systemic lupus erythematosus.
    Sato EI
    Lupus; 2001; 10(3):162-4. PubMed ID: 11315346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
    Islam MN; Hossain M; Haq SA; Alam MN; Ten Klooster PM; Rasker JJ
    Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease).
    Gansauge S; Breitbart A; Rinaldi N; Schwarz-Eywill M
    Ann Rheum Dis; 1997 Jun; 56(6):382-5. PubMed ID: 9227169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate in systemic lupus erythematosus.
    Wong JM; Esdaile JM
    Lupus; 2005; 14(2):101-5. PubMed ID: 15751813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate therapy in childhood systemic lupus erythematosus.
    Abud-Mendoza C; Sturbaum AK; Vazquez-Compean R; Gonzalez-Amaro R
    J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P; Humphrey-Murto S; Gladman DD; Urowitz MB
    J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate use in systemic lupus erythematosus.
    Kipen Y; Littlejohn GO; Morand EF
    Lupus; 1997; 6(4):385-9. PubMed ID: 9175024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy.
    Sakthiswary R; Suresh E
    Lupus; 2014 Mar; 23(3):225-35. PubMed ID: 24399812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methotrexate use in patients with systemic lupus erythematosus].
    Sánchez Y; Carvallo A
    Rev Med Chil; 2004 Feb; 132(2):195-201. PubMed ID: 15449556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR; Abrahamowicz M; Ferland D; Lacaille D; Smith CD; Zummer M;
    Arthritis Rheum; 2008 Dec; 59(12):1796-804. PubMed ID: 19035431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate in systemic lupus erythematosus.
    Walz LeBlanc BA; Dagenais P; Urowitz MB; Gladman DD
    J Rheumatol; 1994 May; 21(5):836-8. PubMed ID: 8064722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
    Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
    Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
    Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of corticodependent systemic lupus erythematosus with low-dose methotrexate].
    Arfi S; Numéric P; Grollier L; Panelatti G; Jean-Baptiste G
    Rev Med Interne; 1995; 16(12):885-90. PubMed ID: 8570950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients.
    Wise CM; Vuyyuru S; Roberts WN
    J Rheumatol; 1996 Jun; 23(6):1005-10. PubMed ID: 8782131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of methotrexate in steroid-resistant systemic lupus erythematosus.
    Rothenberg RJ; Graziano FM; Grandone JT; Goldberg JW; Bjarnason DF; Finesilver AG
    Arthritis Rheum; 1988 May; 31(5):612-5. PubMed ID: 3288223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
    Wilson K; Abeles M
    J Rheumatol; 1994 Sep; 21(9):1674-7. PubMed ID: 7799348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.